6-amino-1-propyl-5-[(R)-pyrrolidin-1-ium-1-yl-(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-dione
C21H31N4O5+ — CID 8891205
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-amino-1-propyl-5-[(R)-pyrrolidin-1-ium-1-yl-(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-dione
6-amino-1-propyl-5-[(R)-pyrrolidin-1-ium-1-yl-(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-dione (PubChem CID 8891205) has the molecular formula C21H31N4O5+ and a molecular weight of 419.50 g/mol. Its IUPAC name is 6-amino-1-propyl-5-[(R)-pyrrolidin-1-ium-1-yl-(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-dione.
Molecular Properties
| Compound Name | 6-amino-1-propyl-5-[(R)-pyrrolidin-1-ium-1-yl-(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-dione |
|---|---|
| PubChem CID | 8891205 |
| Molecular Formula | C21H31N4O5+ |
| Molecular Weight | 419.50 g/mol |
| Exact Mass | 419.23 |
| IUPAC Name | 6-amino-1-propyl-5-[(R)-pyrrolidin-1-ium-1-yl-(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-dione |
| SMILES | CCCn1c(N)c([C@@H](c2cc(OC)c(OC)c(OC)c2)[NH+]2CCCC2)c(=O)[nH]c1=O |
| InChI | InChI=1S/C21H30N4O5/c1-5-8-25-19(22)16(20(26)23-21(25)27)17(24-9-6-7-10-24)13-11-14(28-2)18(30-4)15(12-13)29-3/h11-12,17H,5-10,22H2,1-4H3,(H,23,26,27)/p+1/t17-/m1/s1 |
| InChIKey | KJBHPNQANCKGPR-QGZVFWFLSA-O |
| XLogP | 0.32 |
| TPSA | 113.01 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 419.50 |
| LogP ≤ 5 | 0.32 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 8891205 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.